MedKoo Cat#: 558887 | Name: Cyanine5.5 amine
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cyanine5.5 (Cy5.5® analog) amine derivative. The dye contains a free amine group which can be conjugated with a variety of functionalities, including NHS esters, and epoxides. Cyanine5.5 is a far red dye which works fine for live organism imaging, and applications requiring low fluorescence background.

Chemical Structure

Cyanine5.5 amine
Cyanine5.5 amine
CAS#2097714-45-7 (chloride)

Theoretical Analysis

MedKoo Cat#: 558887

Name: Cyanine5.5 amine

CAS#: 2097714-45-7 (chloride)

Chemical Formula: C46H58Cl2N4O

Exact Mass: 0.0000

Molecular Weight: 753.90

Elemental Analysis: C, 73.29; H, 7.75; Cl, 9.40; N, 7.43; O, 2.12

Price and Availability

Size Price Availability Quantity
1mg USD 350.00 2 Weeks
5mg USD 850.00 2 Weeks
10mg USD 1,450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
2097714-44-6 (without anion) 2097714-45-7 (chloride)
Synonym
Cy5.5 amine; Cy5.5amine; Cy5.5-amine; Cyanine5.5 amine; Cyanine5.5-amine; Cyanine-5.5-amine
IUPAC/Chemical Name
3-(6-((6-ammoniohexyl)amino)-6-oxohexyl)-1,1-dimethyl-2-((1E,3E,5E)-5-(1,1,3-trimethyl-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1H-benzo[e]indol-3-ium chloride
InChi Key
KVJPEAWDFIBHDL-UHFFFAOYSA-N
InChi Code
InChI=1S/C46H56N4O.2ClH/c1-45(2)40(49(5)38-29-27-34-20-13-15-22-36(34)43(38)45)24-10-8-11-25-41-46(3,4)44-37-23-16-14-21-35(37)28-30-39(44)50(41)33-19-9-12-26-42(51)48-32-18-7-6-17-31-47;;/h8,10-11,13-16,20-25,27-30H,6-7,9,12,17-19,26,31-33,47H2,1-5H3;2*1H
SMILES Code
CC1(C)C(/C=C/C=C/C=C2N(C)C3=CC=C(C=CC=C4)C4=C3C/2(C)C)=[N+](CCCCCC(NCCCCCC[NH3+])=O)C5=C1C6=CC=CC=C6C=C5.[Cl-].[Cl-]
Appearance
Solid powder
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 753.90 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Maksimenko, O.; Malinovskaya, Y.; Shipulo, E.; Osipova, N.; Razzhivina, V.; Arantseva, D.; Yarovaya, O.; Mostovaya, U.; Khalansky, A.; Fedoseeva, V.; Alekseeva, A.; Vanchugova, L.; Gorshkova, M.; Kovalenko, E.; Balabanyan, V.; Melnikov, P.; Baklaushev, V.; Chekhonin, V.; Kreuter, J.; Gelperina, S. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastomas: Towards the pharmaceutical development. International Journal of Pharmaceutics, 2019, 572, 118733. doi: 10.1016/j.ijpharm.2019.118733 2. Park, J.; Zhang, Y.; Saito, E.; Gurczynski, S.J.; Moore, B.B.; Cummings, B.J.; Anderson, A.J.; Shea, L.D. Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury. Proceedings of the National Academy of Sciences of the U.S.A., 2019, 116(30), 14947–14954. doi: 10.1073/pnas.1820276116 3. Saito, E.; Kuo, R.; Kramer, K.R.; Gohel, N.; Giles, D.A.; Moore, B.B.; Miller, S.D.; Shea, L.D. Design of biodegradable nanoparticles to modulate phenotypes of antigen presenting cells for antigen-specific treatment of autoimmune disease. Biomaterials, 2019, 222, 119432. doi: 10.1016/j.biomaterials.2019.119432 4. Diaz-Salmeron, R.; Ponchel, G.; Bouchemal, K. Hierarchically built hyaluronic nano-platelets have symmetrical hexagonal shape, flattened surfaces and controlled size. European Journal of Pharmaceutical Sciences, 2019, 133, 251–263. doi: 10.1016/j.ejps.2019.04.007